Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16420 | 28404113 | Lancet Gastroenterol Hepatol | Pathogenesis and novel treatment options for non-alcoholic steatohepatitis. | 2016 | Details |
| A16436 | 28389566 | J Biol Chem | Microbial metabolites in health and disease: Navigating the unknown in search of function. | 2017 | Details |
| A16443 | 28384519 | J Nutr Biochem | Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. | 2017 | Details |
| A16444 | 28383715 | Nutr Rev | Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease. | 2017 | Details |
| A16455 | 28376573 | Aust Fam Physician | The gut microbiome. | 2017 | Details |
| A16459 | 28375406 | J Fam Pract | Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP. | 2017 | Details |
| A16502 | 28349964 | Sci Rep | Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. | 2017 | Details |
| A16503 | 28349245 | J Gastroenterol | Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model. | 2017 | Details |
| A16515 | 28346237 | Curr Opin Gastroenterol | Current and future pharmacologic treatment of nonalcoholic steatohepatitis. | 2017 | Details |
| A16516 | 28345673 | Sci Rep | Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. | 2017 | Details |
| A16521 | 28341485 | Biochim Biophys Acta Gen Subj | Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats. | 2017 | Details |
| A16563 | 28314735 | Gut | Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. | 2017 | Details |
| A16578 | 28298269 | Adv Nutr | Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. | 2017 | Details |
| A16581 | 28297801 | Zhonghua Gan Zang Bing Za Zhi | [Effect of curcumin on intestinal mucosal mechanical barrier in rats with non-alcoholic fatty liver disease]. | 2017 | Details |
| A16587 | 28297790 | Zhonghua Gan Zang Bing Za Zhi | [Role of probiotics in treatment of nonalcoholic fatty liver disease]. | 2017 | Details |
| A16612 | 28283691 | Internist (Berl) | [Modulation of the intestinal microbiota by nutritional interventions]. | 2017 | Details |
| A16632 | 28274625 | Eur J Pharmacol | APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice. | 2017 | Details |
| A16636 | 28271632 | IUBMB Life | The role of insufficient copper in lipid synthesis and fatty-liver disease. | 2017 | Details |
| A16650 | 28265826 | Dig Dis Sci | Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients. | 2017 | Details |
| A16657 | 28260907 | Ther Clin Risk Manag | Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients. | 2017 | Details |
| A16664 | 28257306 | Curr Opin Gastroenterol | Intestinal microbiota and nonalcoholic steatohepatitis. | 2017 | Details |
| A16680 | 28249275 | Dig Dis | Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. | 2017 | Details |
| A16681 | 28249273 | Dig Dis | Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation. | 2017 | Details |
| A16689 | 28242789 | J Lipid Res | TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. | 2017 | Details |
| A16732 | 28218651 | Int J Mol Sci | Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. | 2017 | Details |
| A16733 | 28218263 | Nat Rev Nephrol | Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. | 2017 | Details |
| A16740 | 28214524 | Gastroenterology | Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16746 | 28212301 | Mar Drugs | The Phytocomplex from Fucus vesiculosus and Ascophyllum nodosum Controls Postprandial Plasma Glucose Levels: An In Vitro and In Vivo Study in a Mouse Model of NASH. | 2017 | Details |
| A16751 | 28210913 | Int Urol Nephrol | Dietary and commercialized fructose: Sweet or sour? | 2017 | Details |
| A16752 | 28209760 | Diabetes | Glucoraphanin Ameliorates Obesity and Insulin Resistance Through Adipose Tissue Browning and Reduction of Metabolic Endotoxemia in Mice. | 2017 | Details |
| A16759 | 28201847 | Semin Liver Dis | The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16796 | 28167864 | J Inflamm (Lond) | Ezetimibe reduces cholesterol content and NF-kappaB activation in liver but not in intestinal tissue in guinea pigs. | 2017 | Details |
| A16802 | 28164848 | Gastroenterol Clin North Am | Gut Microbiota and Complications of Liver Disease. | 2017 | Details |
| A16806 | 28162008 | Expert Rev Gastroenterol Hepatol | Clinical implications of understanding the association between oxidative stress and pediatric NAFLD. | 2017 | Details |
| A16838 | 28134687 | Curr Opin Gastroenterol | Fecal microbiota transplantation for gastrointestinal disorders. | 2017 | Details |
| A16895 | 28107283 | J Pediatr Gastroenterol Nutr | NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). | 2017 | Details |
| A16900 | 28104981 | World J Gastroenterol | Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. | 2017 | Details |
| A16923 | 28090564 | Cell Mol Gastroenterol Hepatol | Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease. | 2016 | Details |
| A16950 | 28077318 | Exp Mol Pathol | Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. | 2017 | Details |
| A16955 | 28075092 | Am Fam Physician | Diabetes Mellitus: Management of Gastrointestinal Complications. | 2016 | Details |
| A16962 | 28073414 | Zhonghua Gan Zang Bing Za Zhi | [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease]. | 2016 | Details |
| A16977 | 28067223 | Nat Commun | The microbiota maintain homeostasis of liver-resident γδT-17 cells in a lipid antigen/CD1d-dependent manner. | 2017 | Details |
| A16978 | 28067024 | Mol Nutr Food Res | Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function. | 2017 | Details |
| A16979 | 28065744 | Clin Res Hepatol Gastroenterol | Efficacy and safety of glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2017 | Details |
| A16987 | 28062946 | J Gastroenterol | Upregulated absorption of dietary palmitic acids with changes in intestinal transporters in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
| A17057 | 28018114 | World J Gastroenterol | Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis. | 2016 | Details |
| A17067 | 28011892 | Gut | Adipose type I interferon signalling protects against metabolic dysfunction. | 2016 | Details |
| A17072 | 28008583 | Exp Clin Endocrinol Diabetes | EndoBarrier Gastrointestinal Liner in Type 2 Diabetic Patients Improves Liver Fibrosis as Assessed by Liver Elastography. | 2016 | Details |
| A17074 | 28007354 | Sleep Med | Gut epithelial barrier markers in patients with obstructive sleep apnea. | 2016 | Details |
| A17090 | 27997970 | Semin Liver Dis | The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome. | 2016 | Details |
| A17099 | 27992443 | PLoS One | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD. | 2016 | Details |
| A17135 | 27973438 | Int J Mol Sci | Pathophysiology of Non Alcoholic Fatty Liver Disease. | 2016 | Details |
| A17162 | 27939359 | Pharmacol Res | A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug? | 2016 | Details |
| A17172 | 27935134 | Cell Biochem Funct | Strain- and time-dependent alterations in hepatic iron metabolism in a murine model of nonalcoholic steatohepatitis. | 2016 | Details |
| A17208 | 27913996 | Dig Dis Sci | Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models. | 2016 | Details |
| A17235 | 27895587 | Front Physiol | Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models. | 2016 | Details |
| A17246 | 27890642 | Free Radic Biol Med | Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. | 2016 | Details |
| A17267 | 27879962 | Minerva Endocrinol | Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease. | 2016 | Details |
| A17268 | 27876107 | Br J Nutr | Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation. | 2016 | Details |
| A17318 | 27851786 | PLoS One | Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. | 2016 | Details |
| A17331 | 27837778 | Gastroenterol Clin North Am | Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. | 2016 | Details |
| A17354 | 27826704 | Hepatol Int | Serum-inducible protein (IP)-10 is a disease progression-related marker for non-alcoholic fatty liver disease. | 2016 | Details |
| A17394 | 27780972 | Nat Rev Gastroenterol Hepatol | Developmental origins of NAFLD: a womb with a clue. | 2016 | Details |
| A17403 | 27656762 | Gut Microbes | Hypogonadism alters cecal and fecal microbiota in male mice. | 2016 | Details |
| A17435 | 27605663 | J Biol Chem | Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A17439 | 27787945 | J Diabetes | Personalized microbiome-based approaches to metabolic syndrome management and prevention. | 2017 | Details |
| A17449 | 27784003 | Oncotarget | Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats. | 2016 | Details |
| A17460 | 27778363 | Aliment Pharmacol Ther | Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression. | 2016 | Details |
| A17462 | 27777888 | J Clin Transl Hepatol | Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review. | 2016 | Details |
| A17469 | 27774883 | Curr Mol Med | Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis. | 2016 | Details |
| A17552 | 27311621 | Clin Gastroenterol Hepatol | Use of Antibiotics Among Patients With Cirrhosis and Upper Gastrointestinal Bleeding Is Associated With Reduced Mortality. | 2016 | Details |
| A17557 | 27749006 | Mol Nutr Food Res | An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat "Western-type" diet in mice. | 2016 | Details |
| A17559 | 27745965 | Gastroenterol Hepatol | Role of the gastroenterologist in the management of the obese patient. | 2016 | Details |
| A17570 | 27741171 | J Clin Gastroenterol | Gut Microbiota and the Liver: A Tale of 2 Cities: A Narrative View in 2 Acts. | 2017 | Details |
| A17584 | 27733959 | Cureus | Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A17614 | 27714510 | Dig Dis Sci | Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. | 2016 | Details |
| A17652 | 27688650 | World J Gastroenterol | Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. | 2016 | Details |
| A17653 | 27686615 | Am J Physiol Gastrointest Liver Physiol | Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. | 2016 | Details |
| A17665 | 27678354 | World J Gastroenterol | Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article. | 2016 | Details |
| A17671 | 27672287 | World J Gastroenterol | Anemia and iron deficiency in gastrointestinal and liver conditions. | 2016 | Details |
| A17693 | 27651372 | Pediatr Surg Int | The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome. | 2016 | Details |
| A17713 | 27639801 | Gastroenterology | An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. | 2016 | Details |
| A17718 | 27637587 | J Gastroenterol | Nonalcoholic fatty liver disease in Asia: emerging perspectives. | 2016 | Details |
| A17730 | 27633111 | Adv Nutr | Improvements in Metabolic Health with Consumption of Ellagic Acid and Subsequent Conversion into Urolithins: Evidence and Mechanisms. | 2016 | Details |
| A17749 | 27621581 | World J Gastroenterol | Effects of different diets on intestinal microbiota and nonalcoholic fatty liver disease development. | 2016 | Details |
| A17756 | 27617201 | Mol Metab | Non-alcoholic fatty liver and the gut microbiota. | 2016 | Details |
| A17788 | 27593525 | Diabetes Obes Metab | Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: A randomized crossover study. | 2016 | Details |
| A17827 | 27550547 | Sci Rep | Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease. | 2016 | Details |
| A17829 | 27548822 | Dig Dis | Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis. | 2016 | Details |
| A17830 | 27548720 | Dig Dis | Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction. | 2016 | Details |
| A17862 | 27515958 | Rev Recent Clin Trials | Gut Microbiota and Alcoholic Liver Disease. | 2016 | Details |
| A17876 | 27508070 | F1000Res | Gallstones: new insights into an old story. | 2016 | Details |
| A17887 | 27496089 | Eur J Nutr | Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD). | 2016 | Details |
| A17910 | 27483246 | Int J Mol Sci | The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease. | 2016 | Details |
| A17926 | 27473793 | Surg Clin North Am | A History of Bariatric Surgery: The Maturation of a Medical Discipline. | 2016 | Details |
| A17929 | 27470892 | Zhonghua Gan Zang Bing Za Zhi | [Influence of gut microecology on the pathogenesis and treatment of nonalcoholic fatty liver disease]. | 2016 | Details |
| A18020 | 27409822 | Endocr Pract | GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS. | 2016 | Details |
| A18050 | 27382590 | Int J Community Based Nurs Midwifery | The Effect of Follow up (Telenursing) on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. | 2016 | Details |
| A18065 | 27374784 | Stem Cells | Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A18073 | 27367724 | Nutrients | Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. | 2016 | Details |